NEJM Interview: Dr. Jerry Avorn on a new estimate of the cost of bringing a drug to market.
May 13, 2015
12:09
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Jerry Avorn is a professor of medicine at Harvard Medical School and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. J. Avorn. The $2.6 Billion Pill - Methodologic and Policy Considerations. N Engl J Med 2015;372:1877-9.
NEJM Interviews